General Lakana Santé

The wisdom of the field

I have spent a large part of my time during the last three months in the field, in various parts of rural Mali, trying to ensure that CVD-Mali’s large-scale trials are able to get up and running.

I have also been working on our ongoing COVID-19 research projects and, of course, training and developing the skills of a whole host of field workers, whose expertise and knowledge are crucial to every one of these projects.

It has been a challenging time – there is so much to do and working in the shadow of the COVID-19 pandemic brings with it an array of problems beyond those we might ordinarily encounter. We have done all that we can to ensure that all our co-workers and study subjects are able to take part in CVD-Mali’s vital healthcare projects without compromising their own health.


Lakana commences in Kita!

On Thursday, 15 October 2020, CVD-Mali gave the first doses of Lakana study medicine to young participants in Kita.

The Lakana trial, which is being carried out with funding from the Bill & Melinda Gates Foundation, aims to assess the impact azithromycin has on mortality rates in children aged 1-11 months.

The CVD-Mali team have been working tirelessly for many months to make sure that this vitally-important trial can take place and, at last, the first children have been enrolled, and the first doses swallowed !

This image has an empty alt attribute; its file name is WhatsApp-Image-2020-10-15-at-13.52.10-4.jpeg
Administering the very first dose of Lakana study medicine …